GLAXOSMITHKLINE Australia has advised the Therapeutic Goods Administration (TGA) that its impetigo treatment Bactroban 20mg/g which has been in short supply (PD 01 Jun 16) will become available from Feb this year.
Similarly, Sanofi-Aventis has advised that its ovulatory failure treatment Clomid (clomiphene) is expected to be available again after 30 June 2017.
The TGA also advises that Neo-Mercazole (carbimazole) 5 mg tabs now has limited availability, via a section 19A approval of a UK product, Carbimazole tablets 5mg.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jan 17
